Inhibikase Therapeutics Announces Closing of Initial Public Offering ...Middle East

ATLANTA, Dec. 28, 2020 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase"), a clinical-stage pharmaceutical company developing therapeutics for Parkinson's disease and related disorders that arise inside and outside of the brain, announced today the closing of its...

Hence then, the article about inhibikase therapeutics announces closing of initial public offering was published today ( Monday 28/12/2020 - 07:00 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Inhibikase Therapeutics Announces Closing of Initial Public Offering )

Also on site :

• RECYCLEXPERT FZE Strengthens Leadership in Data Destruction UAE and GCC with Certified Secure ITAD Services
• Zelensky’s inner circle accused of war profiteering
• Rolling Stones Mick Jagger, Keith Richards, and Ronnie Wood Have the Time of Their Life on the Red Carpet